Cipla gains as arm to buy 40% stake in Cipla Pharma Lanka
The stock moved 1.81 per cent higher to trade at Rs 476.50 on the NSE.
Share market update: Nifty Pharma index up; Biocon gains 2%
The Nifty Pharma index was trading 0.09 per cent up at 8253.90.
Glenmark Pharma jumps 21% on CLSA upgrade
YES Securities is also positive on Glenmark Pharma with a 12-month target price of Rs 340.
This defensive play is expected to shine bright over next 2 years
Icra cited abating headwinds from pricing pressure in the US a key growth driver for the sector.
Buy Glenmark Pharma, price target Rs 375: Kunal Bothra
The analyst suggested a stoploss at Rs 340.
Share market update: Nifty Pharma index up; Biocon jumps 5%
The Nifty Pharma index was trading 0.63 per cent up at 8229.40.
JB Chemicals valuations attractive: Analysts
NPPA notified one-time price increase of 50 per cent from existing ceiling price of select 21 National List of Essential Medicines products.
Share market update: Nifty Pharma index up; Glenmark Pharma jumps 6%
The Nifty Pharma index was trading 0.03 per cent up at 7593.90 around 10:12 am.
Share market update: Nifty Pharma index up; Lupin gains 3%
The Nifty Pharma index was trading 0.66 per cent up at 8265.65 .
Credit Suisse maintains neutral on Aurobindo Pharma, target price Rs 500
Neutral Aurobindo Pharma Ltd. at a price target of Rs 500.0 .
Share market update: Nifty Pharma index dips; Piramal Enterprises down 2%
The Nifty Pharma index was trading 0.07 per cent down at 8123.
F&O: Nifty forms higher highs, lows for 4th session, poised to gain more
Momentum oscillator RSI is moving northward and, thus, showing strength in the index.
Strides Pharma relaunches Ranitidine tablets in US
The company had suspended sales of its generic Ranitidine tablets after the USFDA found contamination in some Ranitidine tablets sold by various companies with potentially cancer causing impurities, NDMA. Strides said now the drug meets the limits prescribed by the US drug regulator.
Share market update: Nifty Pharma index down; Aurobindo Pharma slumps 8%
The Nifty Pharma index was trading 0.72 per cent down at 7605.65 around 10:16 am.
Top intraday trading ideas for afternoon trade on Tuesday, December 17, 2019
Vedanta is a 'Buy' call with a target price of Rs 160 and a stop loss of Rs 145.
Copyright © 2020 Bennett, Coleman & Co. Ltd. All rights reserved. For reprint rights: Times Syndication Service